Mecure Industries Reports 52% Revenue Growth in Q1 2026

In the first quarter of 2026, Mecure Industries PLC, led by Kayod Toked, reported a strong financial performance, achieving a revenue of N20.15 billion, which represents a 52% year-on-year growth. The profit before tax (PBT) stood at N1.92 billion, reflecting a 136% increase compared to the previous year, while earnings per share (EPS) rose to N0.34, marking a 143% year-on-year increase.

The Nigerian economy in early 2026 is adjusting to structural reforms, including foreign exchange liberalization and tight monetary policies aimed at curbing inflation, which remains elevated. Mecure's performance is attributed to its strategic investments in local manufacturing, which reduce foreign exchange risk and enhance cost efficiency.

The company has also improved its supply chain diversification and procurement strategies to mitigate input cost volatility. Despite ongoing cost pressures, including high borrowing costs and inflation-driven operational expenses, Mecure maintains strong profit growth through disciplined cost management and a focus on high-margin therapeutic segments.

The company is committed to sustaining growth momentum and expanding its market presence.